IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria
{{output}}
This multicenter study aimed to explore whether baseline total immunoglobulin E (IgE) levels could predict omalizumab response in chronic spontaneous urticaria (CSU) patients. Refractory CSU patients, treated with omalizumab after failing second-generation H1-... ...
